Antivirals Discovery and Development Platform

Antivirals Discovery and Development Platform

The antivirals discovery and development platform offers high throughput analysis of antiviral candidate compounds free of charge to Welsh researchers. Analyses include:

  1. virus infected cell viability/ cell toxicity (selective index);
  2. replicon assays to assess prodrug nucleo-sidic compounds, and
  3. RNA polymerase assays.

Platform data will be fed into dedicated research projects to develop leads and establish MoA. Construction of new replicon tools will be a sideline of the screening effort. The platform promotes collaboration between chemists and life science researchers in Wales and will have a capacity of up to 600 compounds per month.

Antivirals platform Antivirals platform image

For further information please contact:
Dr. Andrea Brancale
Tel.: +44-29-2087-4485
Email: BrancaleA@cardiff.ac.uk